Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
3.950
+0.050 (1.28%)
At close: Jun 8, 2026, 4:00 PM EDT
3.820
-0.130 (-3.29%)
After-hours: Jun 8, 2026, 5:10 PM EDT
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 86 employees as of December 31, 2025. The number of employees increased by 16 or 22.86% compared to the previous year.
Employees
86
Change (1Y)
16
Growth (1Y)
22.86%
Revenue / Employee
$380,512
Profits / Employee
-$638,267
Market Cap
236.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 86 | 16 | 22.86% |
| Dec 31, 2024 | 70 | 14 | 25.00% |
| Dec 31, 2023 | 56 | 11 | 24.44% |
| Sep 30, 2022 | 45 | - | - |
| Jun 30, 2022 | 42 | - | - |
| Mar 31, 2022 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fate Therapeutics | 161 |
| Entrada Therapeutics | 152 |
| Codexis | 146 |
| Coherus Oncology | 145 |
| AC Immune | 122 |
| SAB Biotherapeutics | 86 |
| Protara Therapeutics | 46 |
| Anavex Life Sciences | 34 |
OBIO News
- 4 days ago - Orchestra BioMed Holdings Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 days ago - Orchestra BioMed Holdings Slides: Corporate presentation - Filings
- 6 days ago - Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Orchestra BioMed price target lowered to $10 from $12 at B. Riley - TheFly
- 20 days ago - Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 26 days ago - Orchestra BioMed price target raised to $13 from $12 at Barclays - TheFly
- 27 days ago - Orchestra BioMed reports Q1 EPS (33c), consensus (44c) - TheFly
- 27 days ago - Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates - GlobeNewsWire